These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15772514)

  • 41. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
    Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
    Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.
    Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; Gibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA
    Eur Heart J; 2004 Mar; 25(5):431-6. PubMed ID: 15033256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia.
    Lilyasari O; Subekti Y; Atika N; Dinarti LK; Putri S; Opitasari C; Anggraini AB; Bussabawalai T; Teerawattananon Y
    BMC Health Serv Res; 2019 Aug; 19(1):573. PubMed ID: 31412857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.
    Ghofrani HA; Rose F; Schermuly RT; Olschewski H; Wiedemann R; Kreckel A; Weissmann N; Ghofrani S; Enke B; Seeger W; Grimminger F
    J Am Coll Cardiol; 2003 Jul; 42(1):158-64. PubMed ID: 12849677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Sildenafil as a substitute for subcutaneous prostacyclin in pulmonary hypertension].
    Cea-Calvo L; Escribano Subías P; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
    Arch Bronconeumol; 2003 Oct; 39(10):476-7. PubMed ID: 14533998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term survival of Japanese patients with pulmonary arterial hypertension treated with beraprost sodium, an oral prostacyclin analogue.
    Sakao S; Tanabe N; Kasahara Y; Tatsumi K
    Intern Med; 2014; 53(17):1913-20. PubMed ID: 25175122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia-induced pulmonary hypertension: different impact of iloprost, sildenafil, and nitric oxide.
    Weissmann N; Gerigk B; Kocer O; Nollen M; Hackemack S; Ghofrani HA; Schermuly RT; Butrous G; Schulz A; Roth M; Seeger W; Grimminger F
    Respir Med; 2007 Oct; 101(10):2125-32. PubMed ID: 17643279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension.
    Yanagisawa R; Kataoka M; Taguchi H; Kawakami T; Tamura Y; Fukuda K; Yoshino H; Satoh T
    Circ J; 2012; 76(5):1245-52. PubMed ID: 22333215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension.
    Ikeda D; Tsujino I; Sakaue S; Ohira H; Itoh N; Kamigaki M; Ishimaru S; Atsumi T; Nishimura M
    Circ J; 2007 Nov; 71(11):1829-31. PubMed ID: 17965512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy.
    Jacobs W; Boonstra A; Marcus JT; Postmus PE; Vonk-Noordegraaf A
    J Heart Lung Transplant; 2009 Mar; 28(3):280-4. PubMed ID: 19285621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
    Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
    Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue.
    Vizza CD; Sciomer S; Morelli S; Lavalle C; Di Marzio P; Padovani D; Badagliacca R; Vestri AR; Naeije R; Fedele F
    Heart; 2001 Dec; 86(6):661-5. PubMed ID: 11711462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
    Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
    Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combining treprostinil and sildenafil in the treatment of pulmonary hypertension.
    Chua R; Keogh A
    Intern Med J; 2005 Nov; 35(11):684-5. PubMed ID: 16248867
    [No Abstract]   [Full Text] [Related]  

  • 60. Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotaline-induced pulmonary hypertension.
    Carlino C; Tobias JD; Schneider RI; Heller RL; Alpert MA; Grueber RE; Dellsperger KC; Demarco VG
    Am J Med Sci; 2010 Jan; 339(1):55-9. PubMed ID: 19996941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.